Targeting complement anaphylatoxin C5a receptor in hyperoxic lung injury in mice

Molecular Medicine Reports

Volumn 10, Issue 4, 2014, Pages 1786-1792

  Xu, Ying ^a   Tian, Zhe ^b   Xie, Peiyu ^c  

^a HEILONGJIANG PROVINCIAL HOSPITAL   (China)

^b KUMAMOTO UNIVERSITY   (Japan)

^c KUMAMOTO UNIVERSITY   (Japan)

Author keywords

Complement anaphylatoxin C5a; Hyperoxic lung injury; Macrophage; Receptor antagonist

Indexed keywords

CD68 ANTIGEN, HUMAN; COMPLEMENT COMPONENT C5A RECEPTOR; DIFFERENTIATION ANTIGEN; INTERLEUKIN 6; LEUKOCYTE ANTIGEN; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; PEROXIDASE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL; ANTAGONISTS AND INHIBITORS; BAGG ALBINO MOUSE; CYTOLOGY; GENETICS; HYPEROXIA; LUNG; LUNG INJURY; LUNG LAVAGE; LYMPHOCYTE; MACROPHAGE; METABOLISM; MOUSE; NEUTROPHIL; PATHOLOGY;

ANIMALS; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; BRONCHOALVEOLAR LAVAGE FLUID; CHEMOKINE CCL2; HYPEROXIA; INTERLEUKIN-6; LUNG; LUNG INJURY; LYMPHOCYTES; MACROPHAGES; MICE; MICE, INBRED BALB C; NEUTROPHILS; PEROXIDASE; RECEPTOR, ANAPHYLATOXIN C5A; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84924220354     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2014.2394     Document Type: Article

References (26)

1. Imakiire K, Uto H, Sato Y, et al: Difference in serum complement component C4a levels between hepatitis C virus carriers with persistently normal alanine aminotransferase levels or chronic hepatitis C. Mol Med Rep 6: 259-264, 2012.
2. Hugli TE: Biochemistry and biology of anaphylatoxins. Complement 3: 111-127, 1986.
3. Shagdarsuren E, Bidzhekov K, Mause SF, et al: C5a receptor targeting in neointima formation after arterial injury in atherosclerosis-prone mice. Circulation 122: 1026-1036, 2010.
4. Monk PN, Scola AM, Madala P and Fairlie DP: Function, structure and therapeutic potential of complement C5a receptors. Br J Pharmacol 152: 429-448, 2007. (Pubitemid 47585036)
5. Vitacca M, Bianchi L, Bazza A and Clini EM: Advanced COPD patients under home mechanical ventilation and/or long term oxygen therapy: Italian healthcare costs. Monaldi Arch Chest Dis 75: 207-214, 2011.
6. Vosdoganes P, Lim R, Koulaeva E, et al: Human amnion epithelial cells modulate hyperoxia-induced neonatal lung injury in mice. Cytotherapy 15: 1021-1029, 2013.
7. Pushparaj PN, Tay HK, Wang CC, Hong W and Melendez AJ: VAMP8 is essential in anaphylatoxin-induced degranulation, TNF-alpha secretion, peritonitis, and systemic inflammation. J Immunol 183: 1413-1418, 2009.
8. Lee H, Whitfeld PL and Mackay CR: Receptors for complement C5a. The importance of C5aR and the enigmatic role of C5L2. Immunol Cell Biol 86: 153-160, 2008. (Pubitemid 351301771)
9. Mikawa K, Nishina K, Maekawa N and Obara H: Attenuation of hyperoxic lung injury in rabbits with superoxide dismutase: effects on inflammatory mediators. Acta Anaesthesiol Scand 39: 317-322, 1995.
10. Takao Y, Mikawa K, Nishina K, Maekawa N and Obara H: Lidocaine attenuates hyperoxic lung injury in rabbits. Acta Anaesthesiol Scand 40: 318-325, 1996. (Pubitemid 26106268)
11. Dolinay T, Wu W, Kaminski N, et al: Mitogen-activated protein kinases regulate susceptibility to ventilator-induced lung injury. PLoS One 3: e1601, 2008.
12. Rünzi M, Raptopoulos V, Saluja AK, et al: Evaluation of necrotizing pancreatitis in the opossum by dynamic contrast-enhanced computed tomography: correlation between radiographic and morphologic changes. J Am Coll Surg 180: 673-682, 1995.
13. Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685, 1970.
14. Kyhse-Andersen J: Electroblotting of multiple gels: a simple apparatus without buffer tank for rapid transfer of proteins from polyacrylamide to nitrocellulose. J Biochem Biophys Methods 10: 203-209, 1984.
15. Manthey HD, Woodruff TM, Taylor SM and Monk PN: Complement component 5a (C5a). Int J Biochem Cell Biol 41: 2114-2117, 2009.
16. Naik N, Giannini E, Brouchon L and Boulay F: Internalization and recycling of the C5a anaphylatoxin receptor: evidence that the agonist-mediated internalization is modulated by phosphorylation of the C-terminal domain. J Cell Sci 110: 2381-2390, 1997. (Pubitemid 127699153)
17. Sun S, Wang H, Zhao G, et al: Complement inhibition alleviates paraquat-induced acute lung injury. Am J Respir Cell Mol Biol 45: 834-842, 2011.
18. Rittirsch D, Flierl MA, Day DE, et al: Acute lung injury induced by lipopolysaccharide is independent of complement activation. J Immunol 180: 7664-7672, 2008.
19. Levitt JE, Calfee CS, Goldstein BA, Vojnik R and Matthay MA: Early acute lung injury: criteria for identifying lung injury prior to the need for positive pressure ventilation. Crit Care Med 41: 1929-1937, 2013.
20. Janssen WJ, Barthel L, Muldrow A, et al: Fas determines differential fates of resident and recruited macrophages during resolution of acute lung injury. Am J Respir Crit Care Med 184: 547-560, 2011.
21. Piguet PF, Collart MA, Grau GE, Sappino AP and Vassalli P: Requirement of tumour necrosis factor for development of silica-induced pulmonary fibrosis. Nature 344: 245-247, 1990.
22. Jones SA: Directing transition from innate to acquired immunity: defining a role for IL-6. J Immunol 175: 3463-3468, 2005.
23. Wolters PJ, Wray C, Sutherland RE, et al: Neutrophil-derived IL-6 limits alveolar barrier disruption in experimental ventilator-induced lung injury. J Immunol 182: 8056-8062, 2009.
24. Halbertsma FJ, Vaneker M, Scheffer GJ and van der Hoeven JG: Cytokines and biotrauma in ventilator-induced lung injury: a critical review of the literature. Neth J Med 63: 382-392, 2005. (Pubitemid 41723236)
25. Frank JA, Parsons PE and Matthay MA: Pathogenetic significance of biological markers of ventilator-associated lung injury in experimental and clinical studies. Chest 130: 1906-1914, 2006. (Pubitemid 46033452)
26. Tanaka J, Tajima S, Asakawa K, et al: Preventive effect of irbesartan on bleomycin-induced lung injury in mice. Respir Investig 51: 76-83, 2013.